IncFact
Company Profiles: Revenue, Growth, Competition

PARKER INSTITUTE FOR CANCER IMMUNOTHERAPY Revenue, Growth & Competitor Profile

Last updated:

Company Awards

Brain Power (IP)
Patent/Trademark IP
 

Company Profile & Annual Report for Parker Institute For Cancer Immunotherapy

Access the complete profile.

Parker Institute For Cancer Immunotherapy Fast Facts

Revenue$1 - $10 million    See Exact Annual Revenue
Employees10 - 100Exact Company Size
Primary Industry5417 Scientific Research & Development Services
Address1 Letterman Drive, Ste D3500
San Francisco, CA 94129

parkerici.org
Note: Revenues for privately held companies are statistical evaluations.


Parker Institute For Cancer Immunotherapy's annual revenues are $1-$10 million (see exact revenue data) and has 10-100 employees. It is classified as operating in the Scientific Research & Development Services industry.


Parker Institute For Cancer Immunotherapy's Annual Report & Profile shows critical firmographic facts:
  • What is the company's size? (Annual sales and employees)
  • What industry is the company in?

Parker Institute For Cancer Immunotherapy Annual Revenue and Growth Rate

Parker Institute For Cancer Immunotherapy Revenue Est.
($ Million)
Growth Rate (%)# Employees
2023 Details in Premium Report
2022
2021
2020
2019


1-Year Growth Rate:
3-Year Growth Rate (CAGR):
Premium Report

Note: Parker Institute For Cancer Immunotherapy's revenues are gauged from an analysis of company filings.



Parker Institute For Cancer Immunotherapy's Income Statement (based on Industry Averages)

$ Millions
(Industry Average)
Parker Institute For Cancer Immunotherapy Revenue (Sales) Parker Institute For Cancer Immunotherapy Premium Report
Cost of Goods Sold
Gross Profit

Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit
 


Trademark Applications

Trademark applications show the products and services that Parker Institute For Cancer Immunotherapy is developing and marketing. Parker Institute For Cancer Immunotherapy's new tradmarks suggest it is investing in R&D and marketing, while expanding into new products or markets. Trademarks may include brand names, product names, logos and slogans.

Trademark Date
FROM BENCH TO FIRESIDE
Podcasting services in the fields of scientific and medical research and research projects, medical and scientific clinical trials as well as information in the field of medicine, and medical conditions and treatments
10/18/2023
PICI
Capital investment services; providing grants and funding of scientific and medical research and research projects; charitable foundation services to fund scientific and medical research and research projects
09/11/2023

See all trademarks and details in the Full Report.


Recession Risk

Determine whether Parker Institute For Cancer Immunotherapy grew or shrank during the last recession. This is useful in estimating the financial strength and credit risk of the company. Compare how recession-proof Parker Institute For Cancer Immunotherapy is relative to the industry overall. While a new recession may strike a particular industry, measuring the industry and company's robustness during the last recession estimates its ability to weather future recessions.



U.S. Industry Overview & Market Statistics:
Scientific Research & Development Services

Publisher: AnythingResearch

  • Market Size
  • Growth Rate
  • 5-Year Market Forecast
  • Average Company Size & Growth
  • Salary & Compensation Benchmarks



Market Share of Parker Institute For Cancer Immunotherapy's Largest Competitors

A competitive analysis shows these companies are in the same general field as Parker Institute For Cancer Immunotherapy, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company HeadquartersRevenue ($ MM)
LEIDOSReston, VA100 
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIAAlbuquerque, NM31 
INC RESEARCHRaleigh, NC28 
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORKAlbany, NY17 
FLUOR MARINE PROPULSIONWest Mifflin, PA15 
ILLUMINASan Diego, CA13 
UT-BATTELLEOak Ridge, TN12 
PRA HOLDINGSRaleigh, NC12 
BATTELLE ENERGY ALLIANCEIdaho Falls, ID11 




Nearby Competitors

These companies are similar in business line and location to Parker Institute For Cancer Immunotherapy. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company HeadquartersRevenue ($ MM)
OPENAISan Francisco, CA100 
J.DAVID GLADSTONE INSTITUTESSan Francisco, CA73 
FIRSTLAYERAISan Francisco, CA67 
EMBARK TRUCKSSan Francisco, CA65 
IDEOSan Francisco, CA60 
NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH & EDUCATIONSan Francisco, CA37 




Future Competition: Parker Institute For Cancer Immunotherapy's Fastest Growing Competitors

These companies are in the same general field as Parker Institute For Cancer Immunotherapy and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

CompanyRevenue ($ MM)
Parker Institute For Cancer Immunotherapy Competitors